Factors associated with progression of non‐motor symptoms and deterioration in quality of life in Parkinson's disease: Results of J‐FIRST, a 1‐year observational study

Documenti analoghi

• Hyperthyroidism Can Precipitate Peak‐Dose Levodopa‐Induced Dyskinesia in Parkinson's Disease
  di: Soutarou Taguchi, et al.
  Pubblicazione: (2025)
• Antagonism of metabotropic glutamate receptor type 5 prevents levodopa‐induced dyskinesia development in a male rat model of Parkinson's disease: Electrophysiological evidence
  di: Hikaru Kamo, et al.
  Pubblicazione: (2024)
• Another Microlesion Effect after STN ‐ DBS for Parkinson's Disease
  di: Atsushi Umemura, et al.
  Pubblicazione: (2025)
• Optimized questionnaire item selection for tracking the progression of motor symptoms in Parkinson's disease
  di: Sigfrid, Karl, et al.
  Pubblicazione: (2026)
• Topography of the Philippine Trench.
  di: Iwabuchi, Yoshio, et al.
  Pubblicazione: (1968)